Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-G4h-28-F9Z-TpERt CAR Vector   (CAT#: GTVCR-WQ1212MR)

This product GTVCR-WQ1212MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting CD19. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Chimeric
RefSeq NM_001178098.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 930
UniProt ID P15391
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-G4h-28-F9Z-TpERt CAR Vector (GTVCR-WQ1212MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ805MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFSF13B, BR3-Fc Vector Vector BR3-Fc
GTVCR-WQ402MR IVTScrip™ pSP6-VEE-mRNA-Anti-MS4A1, AME-133v Vector Vector AME-133v
GTVCR-WQ1519MR IVTScrip™ pT7-VEE-mRNA-Anti-IGF1R, IMC-A12 Vector Vector IMC-A12
GTVCR-WQ713MR IVTScrip™ pSP6-VEE-mRNA-Anti-Factor IX substitute, BIIB029 Vector Vector BIIB029
GTVCR-WQ1598MR IVTScrip™ pSP6-VEE-mRNA-Anti-FOLH1, J-591 Vector Vector J-591
GTVCR-WQ2588MR IVTScrip™ pT7-VEE-mRNA-Anti-MAPT, UCB-0107 Vector Vector UCB-0107
GTVCR-WQ2469MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF8, SGN-35 Vector Vector SGN-35
GTVCR-WQ331MR IVTScrip™ pT7-VEE-mRNA-Anti-SLITRK6, AGS15C Vector Vector AGS15C
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.